SUPRIYA.NS Overview

Company Profile

Related stocks

ONESOURCE.NS • India

ONESOURCE SPECL PHARMA L

1,461.3 INR

1.73B USD 1Y -22.7%

CONCORDBIO.NS • India

CONCORD BIOTECH LIMITED

1,361.4 INR

1.47B USD 1Y -14.4%

4743.TWO • Taiwan

ONENESS BIOTECH CO LTD

48.1 TWD

722.78M USD 1Y -26%

005690.KS • South Korea

Pharmicell

12,860 KRW

575.85M USD 1Y +4.7%

476830.KQ • South Korea

Rznomics

26,300 KRW

550.63M USD

2617.HK • China

TRANSTHERA-B

10.43 HKD

541.23M USD 1Y -92.1%

085660.KQ • South Korea

CHA Biotech

8,200 KRW

568.93M USD 1Y -27.7%

456160.KQ • South Korea

G2GBIO

42,000 KRW

518.58M USD 1Y -37.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

48.3% p.a.

Max Drawdown (5Y)

-69.2%

Sharpe Ratio (5Y)

0.31

Beta Factor

0.63

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (48.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -69.2% in the extended horizon.